What is NDC 73473-302?

73473-302 is the product NDC for Clindamycin Phosphate, Clindamycin phosphate 1 g/10mL gel, listed with the FDA by Solaris Pharma Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.

Solaris Pharma Corporation, NDC labeler code 73473. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Clindamycin Phosphate?

70 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Clindamycin Phosphate NDC 73473-302

NDC codes

FDA NDC Directory

Product NDC (as listed)73473-302Labeler and product segments. Claims need a package NDC.

Product NDC at billing width73473-0302Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
73473-302-75	7347303027573473030275	1 BOTTLE in 1 CARTON (73473-302-75) / 75 mL in 1 BOTTLEMarketed from Sep 15, 2024

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Clindamycin Phosphate
Generic name (nonproprietary): clindamycin phosphate
Active ingredients: Clindamycin phosphate — 1 g/10mL
Dosage form: Gel
Route: Topical
Labeler: Solaris Pharma CorporationNDC labeler code 73473
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 212842
Marketing start: Sep 15, 2024
Listing expires: Dec 31, 2026
Other FDA classes: Decreased Sebaceous Gland Activity (Physiologic effect)Lincosamides (Chemical structure)Neuromuscular Blockade (Physiologic effect)
Identifiers: Product ID 73473-302_3a42199c-8c43-4fe7-83fc-4dd5af82279dSPL ID 3a42199c-8c43-4fe7-83fc-4dd5af82279dSPL set ID fde07866-b012-47ad-932e-b76f141f86eeUNII EH6D7113I8UPC 0373473302750
Pharmacologic class: Lincosamide Antibacterial

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N473473030275 followed by a unit qualifier and the quantity

Package 73473-0302-75. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Sep 13, 2024.

Indications (excerpt from the label)

INDICATIONS AND USAGE Clindamycin phosphate gel, 1% is indicated for topical application in the treatment of acne vulgaris. In view of the potential for diarrhea, bloody diarrhea, and pseudomembranous colitis, the physician should consider whether other agents are more appropriate. (See CONTRAINDICATIONS , WARNINGS , and ADVERSE REACTIONS .)

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 73473-302

What is NDC 73473-302?: 73473-302 is the product NDC for Clindamycin Phosphate, Clindamycin phosphate 1 g/10mL gel, listed with the FDA by Solaris Pharma Corporation. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Clindamycin Phosphate.
What is the active ingredient?: Clindamycin phosphate.
Who is the labeler?: Solaris Pharma Corporation, NDC labeler code 73473. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Clindamycin Phosphate?: 70 other product NDCs are listed under this name. See all Clindamycin Phosphate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Clindamycin Phosphate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Clindamycin Phosphate	Clindamycin phosphate 10 mg/mL	SolutionTopical	Rising Pharma Holdings, Inc.	16571-256	16571-0256-6016571-0256-69
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Aurobindo Pharma Limited	59651-806	59651-0806-3059651-0806-60
Clindamycin Phosphateclindamycin phosphate topical	Clindamycin phosphate 10 mg/mL	SolutionTopical	Carnegie Pharmaceuticals, LLC	80005-131	80005-0131-0980005-0131-38
Clindamycin phosphateclindamycin phosphate topical	Clindamycin phosphate 10 mg/mL	SolutionTopical	i3 Pharmaceuticals, LLC	72319-696	72319-0696-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Solaris Pharma Corporation	73473-300	73473-0300-3073473-0300-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Alembic Pharmaceuticals Limited	46708-623	46708-0623-3046708-0623-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Alembic Pharmaceuticals Inc.	62332-623	62332-0623-3062332-0623-60
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	Aerosol, FoamTopical	GLENMARK PHARMACEUTICALS INC., USA	68462-605	68462-0605-2768462-0605-94
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Viona Pharmaceuticals Inc	72578-118	72578-0118-0172578-0118-02
Clindamycin Phosphate	Clindamycin phosphate 10 mg/g	GelTopical	Zydus Lifesciences Limited	70771-1855	70771-1855-0270771-1855-03

All 71 Clindamycin Phosphate NDCs